Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters.
Estevinho, F
Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters. [electronic resource] - Pulmonology - 306-309 p. digital
Publication Type: Letter
2531-0437
10.1016/j.pulmoe.2019.04.005 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials, Phase III as Topic
DNA Mutational Analysis
ErbB Receptors--genetics
Humans
Lung Neoplasms--drug therapy
Mutation
Protein Kinase Inhibitors--therapeutic use
Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters. [electronic resource] - Pulmonology - 306-309 p. digital
Publication Type: Letter
2531-0437
10.1016/j.pulmoe.2019.04.005 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials, Phase III as Topic
DNA Mutational Analysis
ErbB Receptors--genetics
Humans
Lung Neoplasms--drug therapy
Mutation
Protein Kinase Inhibitors--therapeutic use